Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1986 (LINC01986) is a lincRNA gene transcribed from chromosome 3 in humans[4]. By definition, lincRNAs are transcripts longer than 200 nucleotides that do not encode proteins but are involved in regulating gene expression through diverse mechanisms, including acting as scaffolds for chromatin remodeling complexes, modulating nuclear architecture, and functioning as *cis* or *trans* regulatory elements[2][5][7][9]. While thousands of lincRNAs exist, including LINC01986, most have not been functionally characterized in detail, and LINC01986 specifically lacks direct annotation for role in disease or clinical targeting. The functions described for the lincRNA class include fine-tuning developmental and stress-response gene expression and potential involvement in epigenetic regulation, but the functional and pathological significance of LINC01986 remains unclear[1][3][5][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1986 (LINC01986).